[Effect of Escherichia coli heat-labile enterotoxin B subunit on SAG1-ROP2 compound gene vaccine of Toxoplasma gondii tachyzoite].
OBJECTIVE
To investigate the effect of Escherichia coil heat-labile enterotoxin B subunit (LTB) as a genetic adjuvant in enhancing the immune response induced by Toxoplasma gondii tachyzoite compound gene vaccine.


METHODS
The eukaryotic expression plasmids of pcDNA3.1-SAG1-ROP2 and pEASY-E1-LTB were constructed. Eighty-eight BALB/c mice were randomly divided into four groups: PBS (group A), pcDNA3.1(B), pcDNA3.1-SAG1-ROP2 (C) and pcDNA3.1-SAG1-ROP2+pEASY-E1-LTB (D). Fifteen mice in each group were randomly selected, and intranasally immunized weekly with 20 microg plasmid or 20 microl PBS, respectively. Each mouse received four immunizations with the same dose of antigen. Two weeks after the final immunization, the antibodies and cytokines were detected, including the specific IgG and IgA antibodies in serum, sIgA in mucosa douche, IFN-gamma and IL-4 in splenocyte culture supernatant. The remaining mice in each group were immunized three times weekly with 20 microg plasmid or 20 microl PBS, respectively, and challenged by T. gondii tachyzoites at four weeks after the final vaccination (1 x 10(3) per mouse). The survival time of mice was recorded.


RESULTS
The recombinant plasmids pEASY-E1-LTB were constructed. The specific IgG (0.626/- 0.100) and IgA antibodies (1.086 +/- 0.138) in serum, sIgA (0.886 +/- 0.164) in mucosa douche, cytokines IFN-gamma [(2017 +/- 266) pg/ml] and IL-4 [(203.31) pg/ml] in splenocyte culture supernatant in group D were all higher than those in other groups (P < 0.05). After challenged with T. gondii tachyzoites, the median survival time of mice in groups A, B, C, and D were 3, 4, 6, and 10 d, respectively. The survival time of mice in group D was longest (P < 0.05).


CONCLUSIONS
E. coil heat-labile enterotoxin can enhance the immune response induced by the compound gene vaccine of T. gondii tachyzoites.
Zhao
Hong
H
Department of Parasitology, Shandong University School of Medicine, Jinan 250012, China.
He
Shen-yi
SY
Li
Ting
T
Zhao
Guang-hui
GH
Zhou
Huai-yu
HY
Zhao
Qun-li
QL
D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D001427:Bacterial Toxins / Q000276:immunology*; D004768:Enterotoxins / Q000276:immunology*; D029968:Escherichia coli Proteins / Q000276:immunology*; D005260:Female; D051379:Mice; D008807:Mice, Inbred BALB C; D010957:Plasmids; D016052:Protozoan Vaccines / Q000276:immunology*; D014122:Toxoplasma / Q000235:genetics* / Q000276:immunology; D014123:Toxoplasmosis / Q000276:immunology* / Q000517:prevention & control; D019444:Vaccines, DNA / Q000276:immunology*
D000913:Antibodies, Protozoan; D001427:Bacterial Toxins; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D016052:Protozoan Vaccines; D019444:Vaccines, DNA; C027538:heat-labile enterotoxin, E coli